All News

The FDA approval of Fylnetra, a biosimilar for Neulasta, has the potential to offer patients with cancer a neutropenia treatment option at a lower cost.

It’s good to have all the facts when you decide whether to participate in a cancer drug clinical trial—even the ones that make you swallow hard and tear up.

Research showed that Hispanic children with neuroblastoma who are participating on clinical trials tended to have worse survival outcomes than others.

The expertise, guidance and overall compassion of Katherine Caprinolo, B.S.N., RN have quite literally helped me survive these past two years.

My worst fear came true: I was diagnosed with COVID-19 while going through cancer. Now I live my life day by day.

A small percentage of patients with metastatic breast cancer participating in clinical trials in the U.S. are Black, which, according to a patient living with the disease is a huge concern since it doesn’t represent the general population.

In the immediate instance — and that’s where life is lived — I won’t spend my energy fighting against cancer. But that does not mean I don’t care. 

Kymriah, a CAR-T cell therapy, was approved by the Food and Drug Administration for the treatment of patients with pretreated, relapsed/refractory follicular lymphoma.

Both Opdivo plus Yervoy and Opdivo plus chemotherapy were approved by the Food and Drug Administration to treat patients with esophageal squamous cell carcinoma.

Through the support she provides, Stacey eases the load for patients with cancer and doctors alike.

Angela Joseph, RN, is compassionate to both patients with cancer and staffmembers.

I wish all patients had a nurse like Alyssa Johnson, M.S.N., RN.

Candise Jordan, FNP-BC, AONP, always knew that she was going to be a hematology/oncology nurse pratitioner.

Debbie Scoles, RN, has been a source of strength and hope for patients wit hcancer and colleagues alike.

Cheryl’s helpfulness in caring for her patients is very evident, as she is always using her spare time to make sure the patient is comfortable during their stay.

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about genetics in women’s cancer.

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about access to care in women’s cancer.

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about survivorship in women’s cancer.

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about maintaining a healthy lifestyle in women’s cancer.

I didn’t know that starting a blog and turning to social media at the age of 30 after a cancer diagnosis would be so beneficial. But, I’m glad it turned out that way.

I have enjoyed working with Nikki and seeing how she, and all of the other nurses at the Infusion Center in Branson, take care of and interact with the many outpatients that come into the center for service.

An analysis of more than 25,000 patients with one of the more than 20 common cancers identified that even though telehealth use for cancer care increased during the COVID-19 pandemic, certain people were less likely to benefit from the easy access to care.

I can’t imagine not seeing my sister during her blood cancer treatment, but I also struggle to picture the effects of infecting her with COVID-19.

Head and neck cancer treatments and the subsequent side effects can be overwhelming for patients and their caregivers due to the impact they have on routine activities, writes a speech-language pathologist at Cancer Treatment Center of America Atlanta. However, the expert notes, there are plenty of specialists who can help improve patient quality of life.

When I was diagnosed with stage 4 cancer, I was comforted by a simple phrase my oncologist told my husband.

A clinical trial just launched to study Vaxinia — a novel cancer vaccine — in patients with previously treated advanced solid tumors.

Tears flowed as I perfected the art of a quiet, polite breakdown, and then my amazing oncology case manager nurse, Stacey Patterson, B.S.N., RN, OCN, appeared.

The combination of Tibsovo and Vidaza improved progression-free survival and overall survival and presented a favorable safety profile for older patients with acute myeloid leukemia.